Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo.

Zhou X, Bailey-Bucktrout SL, Jeker LT, Penaranda C, Martínez-Llordella M, Ashby M, Nakayama M, Rosenthal W, Bluestone JA.

Nat Immunol. 2009 Sep;10(9):1000-7. doi: 10.1038/ni.1774. Epub 2009 Jul 26.

PMID:
19633673
2.

CD4⁺ T cells from IPEX patients convert into functional and stable regulatory T cells by FOXP3 gene transfer.

Passerini L, Rossi Mel E, Sartirana C, Fousteri G, Bondanza A, Naldini L, Roncarolo MG, Bacchetta R.

Sci Transl Med. 2013 Dec 11;5(215):215ra174. doi: 10.1126/scitranslmed.3007320.

PMID:
24337481
3.

Functional waning of naturally occurring CD4+ regulatory T-cells contributes to the onset of autoimmune diabetes.

Tritt M, Sgouroudis E, d'Hennezel E, Albanese A, Piccirillo CA.

Diabetes. 2008 Jan;57(1):113-23. Epub 2007 Oct 10.

PMID:
17928397
4.

IL-9 induces differentiation of TH17 cells and enhances function of FoxP3+ natural regulatory T cells.

Elyaman W, Bradshaw EM, Uyttenhove C, Dardalhon V, Awasthi A, Imitola J, Bettelli E, Oukka M, van Snick J, Renauld JC, Kuchroo VK, Khoury SJ.

Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):12885-90. doi: 10.1073/pnas.0812530106. Epub 2009 May 11.

PMID:
19433802
5.

Feedback control of regulatory T cell homeostasis by dendritic cells in vivo.

Darrasse-Jèze G, Deroubaix S, Mouquet H, Victora GD, Eisenreich T, Yao KH, Masilamani RF, Dustin ML, Rudensky A, Liu K, Nussenzweig MC.

J Exp Med. 2009 Aug 31;206(9):1853-62. doi: 10.1084/jem.20090746. Epub 2009 Aug 10.

PMID:
19667061
6.

Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate.

Zheng Y, Josefowicz S, Chaudhry A, Peng XP, Forbush K, Rudensky AY.

Nature. 2010 Feb 11;463(7282):808-12. doi: 10.1038/nature08750. Epub 2010 Jan 13.

PMID:
20072126
7.

IL-2 controls the stability of Foxp3 expression in TGF-beta-induced Foxp3+ T cells in vivo.

Chen Q, Kim YC, Laurence A, Punkosdy GA, Shevach EM.

J Immunol. 2011 Jun 1;186(11):6329-37. doi: 10.4049/jimmunol.1100061. Epub 2011 Apr 27.

PMID:
21525380
8.

Following the fate of one insulin-reactive CD4 T cell: conversion into Teffs and Tregs in the periphery controls diabetes in NOD mice.

Fousteri G, Jasinski J, Dave A, Nakayama M, Pagni P, Lambolez F, Juntti T, Sarikonda G, Cheng Y, Croft M, Cheroutre H, Eisenbarth G, von Herrath M.

Diabetes. 2012 May;61(5):1169-79. doi: 10.2337/db11-0671. Epub 2012 Mar 8.

PMID:
22403296
9.
10.

Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.

Brillard E, Pallandre JR, Chalmers D, Ryffel B, Radlovic A, Seilles E, Rohrlich PS, Pivot X, Tiberghien P, Saas P, Borg C.

Exp Hematol. 2007 Mar;35(3):416-25.

PMID:
17309822
12.

Opposing effects of CTLA4 insufficiency on regulatory versus conventional T cells in autoimmunity converge on effector memory in target tissue.

Devarajan P, Miska J, Lui JB, Swieboda D, Chen Z.

J Immunol. 2014 Nov 1;193(9):4368-80. doi: 10.4049/jimmunol.1400876. Epub 2014 Sep 22.

PMID:
25246499
13.

Essential role of NK cells in IgG therapy for experimental autoimmune encephalomyelitis.

Chong WP, Ling MT, Liu Y, Caspi RR, Wong WM, Wu W, Tu W, Lau YL.

PLoS One. 2013;8(4):e60862. doi: 10.1371/journal.pone.0060862. Epub 2013 Apr 5.

PMID:
23577171
14.

Inflammation-driven reprogramming of CD4+ Foxp3+ regulatory T cells into pathogenic Th1/Th17 T effectors is abrogated by mTOR inhibition in vivo.

Yurchenko E, Shio MT, Huang TC, Da Silva Martins M, Szyf M, Levings MK, Olivier M, Piccirillo CA.

PLoS One. 2012;7(4):e35572. doi: 10.1371/journal.pone.0035572. Epub 2012 Apr 24.

PMID:
22545118
15.

Intranasal vaccination with proinsulin DNA induces regulatory CD4+ T cells that prevent experimental autoimmune diabetes.

Every AL, Kramer DR, Mannering SI, Lew AM, Harrison LC.

J Immunol. 2006 Apr 15;176(8):4608-15.

PMID:
16585551
16.

Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice.

Piccirillo CA, Tritt M, Sgouroudis E, Albanese A, Pyzik M, Hay V.

Ann N Y Acad Sci. 2005 Jun;1051:72-87. Review.

PMID:
16126946
17.

Plasticity of T(reg) cells: is reprogramming of T(reg) cells possible in the presence of FOXP3?

Beyer M, Schultze JL.

Int Immunopharmacol. 2011 May;11(5):555-60. doi: 10.1016/j.intimp.2010.11.024. Epub 2010 Nov 27. Review.

PMID:
21115121
18.

Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in self-tolerance and autoimmune disease.

Sakaguchi S, Setoguchi R, Yagi H, Nomura T.

Curr Top Microbiol Immunol. 2006;305:51-66.

PMID:
16724800
19.

IL-2 promotes the function of memory-like autoregulatory CD8+ T cells but suppresses their development via FoxP3+ Treg cells.

Shameli A, Yamanouchi J, Tsai S, Yang Y, Clemente-Casares X, Moore A, Serra P, Santamaria P.

Eur J Immunol. 2013 Feb;43(2):394-403. doi: 10.1002/eji.201242845. Epub 2013 Jan 15.

PMID:
23180662
20.

An intersection between the self-reactive regulatory and nonregulatory T cell receptor repertoires.

Hsieh CS, Zheng Y, Liang Y, Fontenot JD, Rudensky AY.

Nat Immunol. 2006 Apr;7(4):401-10. Epub 2006 Mar 12.

PMID:
16532000

Supplemental Content

Support Center